1
|
Rosen PP: Carcinoma with metaplasia.
Rosen’s Breast Pathology. 3rd edition. Lippincott Williams and
Wilkins; Philadelphia, PA: pp. 470–505. 2009
|
2
|
Yamaguchi R, Horii R, Maeda I, et al:
Clinicopathologic study of 53 metaplastic breast carcinomas: their
elements and prognostic implications. Hum Pathol. 41:679–685. 2010.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Wargotz ES and Norris HJ: Metaplastic
carcinomas of the breast. I Matrix-producing carcinoma. Hum Pathol.
20:628–635. 1989. View Article : Google Scholar : PubMed/NCBI
|
4
|
Wargotz ES, Deos PH and Norris HJ:
Metaplastic carcinomas of the breast. II Spindle cell carcinoma.
Hum Pathol. 20:732–740. 1989. View Article : Google Scholar : PubMed/NCBI
|
5
|
Wargotz ES and Norris HJ: Metaplastic
carcinomas of the breast. III Carcinosarcoma. Cancer. 64:1490–1499.
1989. View Article : Google Scholar : PubMed/NCBI
|
6
|
Wargotz ES and Norris HJ: Metaplastic
carcinomas of the breast. IV Squamous cell carcinoma of ductal
origin. Cancer. 65:272–276. 1990. View Article : Google Scholar : PubMed/NCBI
|
7
|
Wargotz ES and Norris HJ: Metaplastic
carcinomas of the breast: V. Metaplastic carcinoma with
osteoclastic giant cells. Hum Pathol. 21:1142–1150. 1990.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Weigelt B and Reis-Filho JS: Histological
and molecular types of breast cancer: is there a unifying taxonomy?
Nat Rev Clin Oncol. 6:718–730. 2009. View Article : Google Scholar : PubMed/NCBI
|
9
|
Schmitt FC and Reis-Filho JS: Oncogenes,
granules and breast cancer: what has c-myc to do with apocrine
changes? Breast. 11:463–465. 2002. View Article : Google Scholar
|
10
|
Selim AG and Wells CA: Immunohistochemical
localisation of androgen receptor in apocrine metaplasia and
apocrine adenosis of the breast: relation to oestrogen and
progesterone receptors. J Clin Pathol. 52:838–841. 1999. View Article : Google Scholar
|
11
|
Tsutsumi Y: Apocrine carcinoma as
triple-negative breast cancer: novel definition of apocrine-type
carcinoma as estrogen/progesterone receptor-negative and androgen
receptor-positive invasive ductal carcinoma. Jpn J Clin Oncol.
42:375–386. 2012. View Article : Google Scholar
|
12
|
Japaze H, Emina J, Diaz C, et al: ‘Pure’
invasive apocrine carcinoma of the breast: a new
clinicopathological entity? Breast. 14:3–10. 2005.
|
13
|
Toikkanen S: Primary squamous cell
carcinoma of the breast. Cancer. 48:1629–1632. 1981. View Article : Google Scholar : PubMed/NCBI
|
14
|
Yamaguchi R, Tanaka M, Kondo K, et al:
Immunohistochemical study of metaplastic carcinoma and central
acellular carcinoma of the breast: central acellular carcinoma is
related to metaplastic carcinoma. Med Mol Morphol. 45:14–21. 2012.
View Article : Google Scholar
|
15
|
Frable WJ and Kay S: Carcinoma of the
breast. Histologic and clinical features of apocrine tumors.
Cancer. 21:756–763. 1968. View Article : Google Scholar : PubMed/NCBI
|
16
|
Abati AD, Kimmel M and Rosen PP: Apocrine
mammary carcinoma. A clinicopathologic study of 72 cases. Am J Clin
Pathol. 94:371–377. 1990.PubMed/NCBI
|
17
|
Vranic S, Tawfik O, Palazzo J, et al: EGFR
and HER-2/neu expression in invasive apocrine carcinoma of the
breast. Mod Pathol. 23:644–653. 2010. View Article : Google Scholar : PubMed/NCBI
|
18
|
Gatalica Z: Immunohistochemical analysis
of apocrine breast lesions. Consistent over-expression of androgen
receptor accompanied by the loss of estrogen and progesterone
receptors in apocrine metaplasia and apocrine carcinoma in situ.
Pathol Res Pract. 193:753–758. 1997.
|
19
|
Niemeier LA, Dabbs DJ, Beriwal S, Striebel
JM and Bhargava R: Androgen receptor in breast cancer: expression
in estrogen receptor-positive tumors and in estrogen
receptor-negative tumors with apocrine differentiation. Mod Pathol.
23:205–212. 2010. View Article : Google Scholar
|
20
|
Honma N, Takubo K, Akiyama F, et al:
Expression of GCDFP-15 and AR decreases in larger or node-positive
apocrine carcinomas of the breast. Histopathology. 47:195–201.
2005. View Article : Google Scholar : PubMed/NCBI
|
21
|
Tanaka K, Imoto S, Wada N, Sakemura N and
Hasebe K: Invasive apocrine carcinoma of the breast:
clinicopathologic features of 57 patients. Breast J. 14:164–168.
2008. View Article : Google Scholar : PubMed/NCBI
|
22
|
Ogiya A, Horii R, Osako T, et al: Apocrine
metaplasia of breast cancer: clinicopathological features and
predicting response. Breast Cancer. 17:290–297. 2010. View Article : Google Scholar : PubMed/NCBI
|
23
|
Sapp M, Malik A and Hanna W: Hormone
receptor profile of apocrine lesions of the breast. Breast J.
9:335–336. 2003. View Article : Google Scholar : PubMed/NCBI
|